Abstract: PIP5K1β is crucial to generation of phosphotidylinosotol (4, 5) P 2 .
Introduction
Bone remodeling depends on the dynamic balance and precise coordination of bone resorption and subsequent bone formation, which are driven by osteoclast and osteoblast activation, respectively. Disturbances of this delicate balance lead to skeletal diseases, such as osteopenia, osteoporosis and osteopetrosis (Boyle et al, 2003) .
Bone-resorbing osteoclasts are multinucleated cells derived from monocyte-macrophage precursors which originated from hematopoietic stem cells, whereas bone-forming osteoblasts are derived from mesenchymal stem cells (MSC) (Boyle et al, 2003; Dennis et al, 1999; Pittenger et al, 1999; Teitelbaum, 2000) .
Osteoblast lineage cells produce RANKL and stimulate their RANK receptors on osteoclast precursors, resulting in osteoclast differentiation by activating the downstream signaling pathways such as transcription factors NF-κB, c-Fos, and nuclear factor of activated T cells c1 (NFATc1) (Teitelbaum & Ross, 2003) . To initiate bone resorption, osteoclasts need to successfully assemble a typical adhesion structure that is called actin ring or sealing zone, which consists of a belt of densely packed podosomes interlinked by an acto-myosin network (Georgess et al, 2014; Touaitahuata et al, 2014) .
Exacerbated by general population aging, osteoporosis has become a dominating health problem around the world (Sambrook & Cooper, 2006) . Various conditions can provoke osteoporosis, such as bone metastasis, disability and inflammation, furthermore, in postmenopausal women, estrogen deficiency gives rise to excessive bone loss. (Touaitahuata et al, 2016) Despite recent advances in bone biology, the precise molecular mechanisms responsible for pathological osteoporosis remain elusive. Therefore, clarifying the molecular mechanisms and novel molecules involved in the maintenance of bone homeostasis is critical for deeper understanding of skeletal health and development of novel therapeutics against various bone disorders.
Lipid kinases and their phosphoinositide products perform essential functions in secretory vesicle trafficking. Phosphoinositide (PI) contributes to numerous basic biological processes, such as chemotaxis, intercellular trafficking, polarity formation and cytokinesis. (Takenawa & Itoh, 2001 ) PIs are essential not only as membrane components in Eukaryotes and as precursors of second messengers like IP3 and PIP3 but also act as specialized membrane docking sites for effectors of diverse signaling cascades. (Takenawa & Itoh, 2001 ) Accumulating evidence indicates that PIs and PI-interacting proteins such as Rho, Arf, and Rab small GTPases serve as modulators of osteoclast differentiation. (Chellaiah, 2006; Ory et al, 2008) PIs, especially PIP2, PIP3
and IP3, have been reported to serve various essential roles during osteoclast differentiation and function as well as in maintain bone homeostasis. PIP5K1β is a member of the Type 1 phosphatidylinositol 4-phosphate 5-kinases (PIP5K1s; α, β, and γ), which are a family of isoenzymes producing phosphatidylinositol 4, 5-bisphosphate
[PI (4, 5)P2] using phosphatidylinositol 4-phosphate as substrate (De Matteis & Godi, 2004; Ishihara et al, 1996; Ishihara et al, 1998; Kanaho et al, 2007; Oude Weernink et al, 2004; van den Bout & Divecha, 2009 ). PIP5K1s have been reported to be involved in a wide range of cellular functions not only as an enzyme generating PIP2, which is a critical regulator of cell adhesion formation, actin dynamics, and membrane trafficking, but also as cell signaling modulation factor, such as cytoskeleton assembly, exocytosis, endocytosis, cell apoptosis, and so on (Mao & Yin, 2007; van den Bout & Divecha, 2009 ). PIP5k1γ, which is a major PtdIns (4,5)P2-synthesising enzyme in the rodent brain with three splicing variants, is elegantly involved in neurons and neuroendocrine cells: Hara Y et al reported that PIP5K1γ, particularly PIP5K1γ_i2, performs essential roles in neuronal migration, possibly through recruitment of adhesion components such as talin and focal adhesion kinase to the plasma membrane. (Hara et al, 2013) In murine megakaryocytes, PIP5K1γ defect results in plasma membrane blebbing accompanied by a decreased connection of the membrane to the cytoskeleton possibly through a pathway involving talin. (Wang et al, 2008b) Moreover, PIP5K1γ_i2 revealed unique regulatory and targeting mechanisms through its C-terminal 26 amino acids. In neurons, PIP5K1γ_i2 modulates the clathrin-mediated endocytosis of synaptic vesicles at presynapses and α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate-type glutamate receptors during long-term depression at postsynapses via association with adaptor protein complex (AP)-2 (Unoki et al, 2012) . In non-neuronal cells, PIP5K1γ_i2 also regulates the formation of focal adhesions through the interaction with talin. (Di Paolo et al, 2002; Ling et al, 2002; Sun et al, 2007) Furthermore, targeted disruption of PIP5K1γ leads to widespread developmental and cellular defects. PIP5K1γ-null embryos have myocardial developmental defects including impaired intracellular junctions resulting in heart failure and extensive lethality at embryonic day 11.5 as well as impaired PIP2 production, adhesion junction formation, and neuronal cell migration that lead to neural tube closure defects. (Wang et al, 2007) PIP5k1α, was reported to selectively modulate apical endocytosis in polarized renal epithelial cells and to regulate invadopodia formation and ECM degradation in human breast cancer cells by localized production of PI(4,5)P(2) (Szalinski et al, 2013) . The function of PIP5k1β was investigated less and the roles of PIP5k1s in maintaining bone homeostasis were rarely reported. Only one report indicated that PIP5k1γ deficiency or overexpression delayed osteoclast differentiation and excess of PIP5k1γ disrupted osteoclasts cytoskeleton in a talin-independent way. (Zhu et al, 2013) In the present study, we found that PIP5k1β was highly expressed during RANKL-induced osteoclast differentiation and PIP5k1β deletion in mice resulted in bone loss. To further understand the role of PIP5k1β in bone homeostasis, we investigated the functions of PIP5k1β acting on osteoclast and osteoblast differentiation by gain-and loss-of-function in vitro. We found that PIP5K1β can repress the proliferation and migration of bone-marrow-derived macrophage-like cells (BMMs) to inhibit osteoclast differentiation. Furthermore, PIP5k1β deletion promoted the activation of MAPK and Akt signaling cascades and enhanced expression of TRAF6 and c-Fos to facilitate NFATC1 expression and nuclear translocation, thereby accelerating osteoclast differentiation and function. Last but not the least, PIP5k1β deficiency upregulated Grb2 expression during osteoclast differentiation. PIP5K1β also enhanced osteoblast differentiation through activating of smad1/5/8. Thus, PIP5K1β can regulate bone mass and bone remodeling.
Results

PIP5k1β-deficient mice show an osteoporosis bone phenotype.
Having demonstrated that PIP5k1γ served an essential role in modulating osteoclast differentiation and that it must be expressed at an actually exact level to maintain normal differentiation of osteoclast. (Zhu et al, 2013) To determine the role of PIP5k1β in the skeleton, we evaluated the mutant mouse strain with piggyback (PB) transposition system-induced mutation in the PIP5k1β gene. Homozygous mutation of PIP5k1β were born healthy at the predicted Mendelian frequencies. PIP5k1β −/− mice had a similar body structure to that of WT littermates with no obvious differences observed between PIP5k1β −/− and WT controls ( Supplementary Fig. 1A (Fig. 1G, H) . Analysis of osteoclast parameters using TRAP stained sections showed that PIP5k1β −/− mice exhibited a significant increase in the number of osteoclasts (Fig. 1G, I ). Moreover, Dynamic histomorphometric analysis detected the reduced bone formation rate and mineral apposition rate in PIP5k1β −/− mice (Fig. 1J, K) .
Furthermore, the serum levels of CTX-1, a marker for bone resorption, was significantly increased (Fig. 1L ) but serum OCN levels, a marker for bone formation, was dramatically decreased (Fig. 1O ) in PIP5k1β −/− mice. Moreover, immunohistochemistry detected that expression of CTSK, one of major markers of mature osteoclasts, in PIP5k1β deletion mice was significantly higher than that in wide type mice ( Fig. 1M-N) . These accumulating results suggest that PIP5k1β deletion leads to significant decrease in bone mass, which is possibly due to imbalance changes in osteoclasts bone resorption and osteoblasts bone formation.
PIP5k1β expression was increased during RANKL-induced osteoclast differentiation.
Thereby, to determine how PIP5k1β influences osteoclasts formation and function, we first examined the transcriptomes of preosteoclasts and mature osteoclasts differentiated from mouse bone marrow-derived macrophage-like cells (BMMs) using cDNA microarray and found that among PIP5k1s only PIP5k1β was highly expressed in mature osteoclasts. (Fig. 2A) . When we cultured BMMs in the presence of RANKL and M-CSF, the expression of PIP5k1β was markedly increased during RANKL-induced osteoclast differentiation since the third day of RANKL induction, however, the expressions of PIP5k1α and PIP5k1γ were not changed (Fig. 2B, Fig.3B ).
Expression levels of VATPased2 and TRAP, important markers of osteoclastogenesis, increased as the cells differentiated (Fig. 2B) . To confirm the importance of PIP5k1β in skeletal biology, we explored the expression pattern of PIP5k1β in different mice organs such as bone, spleen, brain, thymus, lung, kidney, liver, heart, and muscle and found that PIP5k1β was highly expressed in heart, lung, brain and bone ( Supplementary Fig. 1B ), which indicated that PIP5k1β might play a crucial role in bone biology. These results indicate that PIP5k1β might be involved in regulation of osteoclastogenesis and bone remodeling.
PIP5k1β-deficient osteoclasts exhibit normal morphology.
Accumulating evidences demonstrated that PIP5k1 family kinase serve central roles in cytoskeleton assembly (Kisseleva et al, 2005; Rozelle et al, 2000; Shibasaki et al, 1997; van den Bout & Divecha, 2009; van Horck et al, 2002; Wang et al, 2008b ), so we give rise to the hypothesis that PIP5k1β deficient may affect osteoclast cytoskeleton.
To verify this hypothesis, we detect the actin ring formation as well as the localization of vinculin and Rac1, which are critical factors that can contribute to the ability of osteoclasts to rearrange podosomes into the sealing zone and establish the bone-resorbing apparatus, through classical confocal microscopy (Croke et al, 2011; Fukunaga et al, 2014; Ory et al, 2000; Sun et al, 2005; Wang et al, 2008a) . F-actin exhibits a similar well-defined peripheral belt architecture in both WT and PIP5k1β-deficient osteoclast, and PIP5k1β deletion promotes podosome formation in preosteoclasts and PIP5k1β deletion osteoclasts display much larger actin rings compared with WT osteoclasts. Vinculin and Rac1 localization and expression are also normal in PIP5k1β-deletion osteoclasts, which are all enriched at the podosome belt and are colocalized with F-actin (Touaitahuata et al, 2016) (Figure. 2C) . Finally, the expression levels of β3 integrin, which involves in the association of osteoclasts with bone matrix to trigger osteoclast bone resorption activity, was also uninfluenced by PIP5k1β deficiency ( Supplementary Fig. 1C, D) .These results indicate that PIP5k1β deletion accelerates actin ring formation but does not affect osteoclast cytoskeleton assembly and sealing zone formation as well as interaction ability with bone matrix on the whole. To explore the mechanisms of PIP5k1β inhibition of osteoclast differentiation, we examined the effect of PIP5k1β on BMMs proliferation and migration. The wound healing assay displayed that PIP5k1β deletion promotes preosteoclasts migration triggered not only by M-CSF or by both M-CSF and RANKL (Fig. 5A , B). The CCK8 assay showed that PIP5k1β deficiency enhanced BMMs proliferation under the induction of RANKL and M-CSF, whereas only RANKL or M-CSF had no significant effect on the proliferation of BMMs (Fig. 5C ). Furthermore, PIP5k1β deficiency facilitated NFATC1 expression and nuclear translocalization when triggered by RANKL detected by classical confocal microscopy and western blotting ( Fig. 5D -E).
Deficiency of
Besides, luciferase assay with a NFATC1 responsive reporter was strongly dampened by PIP5k1β overexpression under the stimulation of RANKL ( Fig. 5F -G). These results implied that PIP5k1β suppressed osteoclast differentiation by depressing preosteoclast proliferation, migration and also reducing NFATC1 signaling by decreasing its expression and nuclear translocalization.
Deficiency of PIP5k1β leads to increases of M-CSF-and RANKL-mediated MAPK, c-Fos and AKT signaling cascades.
PIP5k1β was discovered to be highly expressed during RANKL-mediated osteoclastogenesis and PIP5k1β suppressed osteoclast formation and bone resorption capacity. We asked which signaling pathway modulated osteoclast differentiation and whose function is affected by the absence of PIP5K1β, which in turn affected osteoclastogenesis. First, we examined the archetypical RANKL signaling mediators such as c-Fos, TRAF6, NFATC1, Cathepsin K (CTSK) and TRAP, and found that deletion of PIP5k1β prominently enhanced the expression of these genes during RANKL-mediated osteoclstogenesis ( Fig. 3E-F for JNK and ERK1/2, compared with WT BMMs (Fig.6K-N) . Notably, the expressions of Grb2 was also enhanced during RANKL-mediated osteoclastogenesis in PIP5k1β −/− osteoclasts compared with WT osteoclasts (Fig.6A) . The adaptor protein 
PIP5k1β accelerates osteoblast differentiation.
Given that the serum bone formation marker OCN was significantly decreased in PIP5k1β −/− mice compared with WT mice, we explored the effect of PIP5k1β on osteoblast differentiation and function to deepen our understanding of the role of PIP5k1β in bone homeostasis. First, immunohistochemistry revealed that expression of OSX, one of major transcriptional factors that control osteoblast differentiation, in PIP5k1β deletion mice was notably lower than that in wide type mice ( Fig. 7A-B) .
Then, BMSCs constantly overexpress or knockdown of PIP5k1β were obtained by corresponding lentivirus transfection ( Fig. 7C ) and underwent osteoblast differentiation by stimulation with osteogenic medium. MTT assay revealed that knockdown or overexpression of PIP5k1β have no effect on BMSCs proliferation (Supplementary Fig.2A ). Real-time PCR was performed to determine whether osteoblast marker genes were differentially expressed between WT and PIP5k1β overexpression osteoblasts. The mRNA levels of PIP5k1β were significantly enhanced during osteoblast differentiation and the mRNA expression of osteoblast marker genes, ALP, SP7, colla1, OCN and BSP, were increased by overexpression of
Increased ALP activity was observed in PIP5k1β-overexpression osteoblasts at day 7 of culture and decreased ALP activity was observed in PIP5k1β-knockdown osteoblasts at day 7 of culture as compared to WT osteoblasts by ALP staining (Fig. 7L ). The bone mineralization activity of osteoblasts derived by BMSCs constantly overexpression or knockdown of PIP5k1β was also altered consistently with ALP activity alteration relative to WT osteoblasts, as determined by alizarin red S staining and analysis at day 14 of culture ( Fig. 7M) .
Furthermore, the protein levels of Col1α1, RUNX2 and OSX, which were central marker genes of osteoblastogenesis were all enhanced via PIP5k1β overexpression and decreased when PIP5k1β was knockdown. (Fig. 7N, supplementary Fig. 2B-C) . These results implied that PIP5k1β enhanced MSCs differentiation into osteoblast.
PIP5k1β enhances osteoblast differentiation through activating p-Smad1/5/8 signaling.
Several signaling pathways were involved in regulation of BMSCs differentiation into osteoblast, of which smad1/5/8 signaling exerts crucial roles in osteogenesis. To understand through which pathways PIP5k1β modulates osteoblast differentiation, we tested the activation of main pathways that regulates MSCs differentiation into osteoblast including smad1/5/8 and β-catenin and found that PIP5k1β prominently modulates smad1/5/8 activation. The phosphorylation of smad1/5/8 was significantly increased after 7 and 14 days treatment with osteogenic medium compared with cells treated with control medium, while, knockdown of PIP5k1β drastically depressed smad1/5/8 phosphorylation but overexpression of PIP5k1β outstandingly increased its phosphorylation on the contrary (Fig. 8A-B) . To refine this finding, we further treated BMSCs with LDN193189, a smad1/5/8 specific inhibitor, to eliminate the activation of smad1/5/8. We observed that PIP5k1β overexpression prominently enhanced osteoblast differentiation and LDN193189 significantly reduced osteogenesis, but the reduction ratio was partly rescued by overexpression of PIP5k1β ( Fig. 8C-E) . Western blotting showed that PIP5k1β overexpression violently enhanced osteoblastogenesis master genes, Col1α1, Runx2 and OSX, expression, and LDN193189 significantly inhibited expression of these genes, but the inhibition ratio was partly rescued by overexpression of PIP5k1β. Meanwhile, Phosphorylation of smad1/5/8 was changed in consistent with the change trend of these osteoblastogenesis master genes. (Fig. 8F ).
In summary, these observations indicated that PIP5k1β enhances BMSCs differentiation into osteoblast partly through activating smad1/5/8 signaling.
Discussion
Several therapeutic strategies have been developed for excess bone loss diseases such as osteoporosis, including direct suppression of osteoclasts resorption capacity or irritation of osteoblast bone formation, with compromised efficacy and momentous side effects. Therefore, more appropriate treatments need to be explored to synchronously modulate the interaction between osteoblasts and osteoclasts. In present study, we discovered that PIP5K1β inhibited osteoclasts formation and function but meanwhile facilitated osteoblast differentiation, so that PIP5k1β −/− displayed obvious osteoporosis phenotype. These hinted that PIP5K1β might serve pivotal roles in maintaining bone homeostasis and that deepening understanding of the mechanisms of its functional role might provide new strategy for the prevention and treatment of osteoporosis.
Among all the family members of PIP5k1 family kinases that generate PIP2, only
PIP5k1β was highly expressed in bone and during osteoblastogenesis and RANKL-induced osteoclast differentiation, which indicated that PIP5k1β might serve crucial roles in bone biology. Under the consideration that PIP5k1 family proteins were reported to be involved in cytoskeleton assembly and that the podosome reorganization of osteoclasts was a major event for mature osteoclasts formation and activity (Mao & Yin, 2007; Teitelbaum, 2011; van den Bout & Divecha, 2009 ), we speculated that PIP5k1β might participate in osteoclast sealing zone organization.
However, our present study showed that PIP5k1β deletion osteoclasts exhibit no apparent cytoskeletal abnormalities and also had no impact on the expression and colocalization of proteins involved in sealing zone formation, such as vinculin, Rac1
and F-actin. Additionally, the expression levels of β3 integrin, which takes part in the association of osteoclasts with bone matrix to trigger the osteoclast bone resorption activity, was also uninfluenced by PIP5k1β deficiency ( Supplementary Fig. 1C, D) . Osteoclasts are generated from mononuclear hematopoietic myeloid lineage cells, which are derived in the bone marrow and are attracted to the blood stream by factors.
These circulating precursors migrated to bone surfaces undergoing resorption by chemokines and other factors that were modulated by M-CSF and RANKL at these sites, where they fuse to develop multinucleated bone resorbing cells (Kikuta et al, 2011; Kular et al, 2012) . Interestingly, in the present study, we obtained that PIP5k1β (Wang et al, 1992) PIP5K1γ was reported to modulate calcium transport, which in turn, initiated NFATc1 (Wang et al, 2004) . Moreover, NFATC1 can autoamplify and trigger calcitonin receptor expression which eventually upregulated calcium signaling (Asagiri et al, 2005) . Further studies need to be performed to determine if PIP5k1β deletion affects calcium signaling.
Adaptor protein Grb2 (growth-factor-receptor-bound protein 2), which serves an important role in several tyrosine kinase signal transduction pathways, was reported to play a crucial role in osteoclastogenesis by increasing Erk and Akt signaling motivated discovered in the present study that Grb2 expression was advanced and dramatically up-regulated during osteoclastogenesis while PIP5k1β was deleted, besides, the ERK1/2 signaling was also enhanced. These implied that PIP5k1β might modulate Grb2 expression to regulate osteoclastogenesis. However, further study is needed to make deep insight in the association between PIP5k1β and Grb2 expression.
Our present work also discovered that PIP5k1β facilitated osteoblast differentiation, immunohistochemistry in These accumulating evidences implied that PIP5k1β facilitates osteoblast differentiation from BMSCs partly through smad1/5/8 signaling.
In summary, our study explored the role of PIP5k1β in bone biology, particularly in osteoclast and osteoblast differentiation and function, for the first time. We found that PIP5K1β was highly expressed both during osteoclast and osteoblast differentiation and PIP5K1β can regulate bone mass and bone remodeling by inhibiting osteoclast differentiation and facilitating osteoblast differentiation. (Supplementary Fig.   2D ) Further studies need to be performed to determine if these functions were partly caused by PIP2 levels alteration that was contributed by PIP5k1β kinase activity during osteoclast and osteoblast differentiation. Besides, further explanation of the RANKL modulation of PIP5k1β expression is needed to deepen our understanding of the biological roles of PIP5k1β on maintaining bone homeostasis to explore new targets for prevention and treatment of bone disorders.
Materials and Methods
Reagents. Alpha-minimum essential medium (MEM), fetal bovine serum (FBS), and penicillin were purchased from Gibco BRL (Gaithersburg, MD, USA).
Recombinant mouse macrophage-colony stimulating factor (M-CSF) was purchased from R&D Systems (USA). Recombinant Murine sRANK Ligand was purchased from Peprotech (USA). Tartrate plates at a density of 8×10 3 cells/well in triplicate and incubated with α-MEM medium containing 20 ng/ml M-CSF in a humidified incubator containing 5% CO2 at 37℃ for 2 d. Then, the cells were cultured with α-MEM medium with M-CSF (20 ng/mL) and RANKL (75 ng /mL; 315-11; Peprotech; Rocky Hill, NJ) for indicated times. Moreover, the medium was changed every other day. For osteoblast differentiation, bone mesenchymal stem cells (BMSCs) were gained from 9-to 10-week-old mice and expanded as previously described, induced by culturing cells in osteogenic medium (DMEM containing 1M β-glycerophosphate, 50mM ascorbic acid and 1mM Dex (methylisobutylxanthine)) for indicated times, followed by subsequent experiments.
TRAP activity assay. After 7 days of culture, the osteoclasts were fixed with 4%
paraformaldehyde (PFA) in PBS for 10 min and then rinsed three times with PBS, followed by TRAP staining, using an acid phosphatase kit (387A; Sigmae Then the bone slices were fixed with 2.5% glutaraldehyde and followed by visualization with scanning electron microscope (SEM; FEI Quanta 250). Pit areas were quantified with Image J software (National Institutes of Health). Similar independent experiments were repeated three times.
Cell proliferation and migration assay. The proliferation rate was determined with CCK-8 assay according to the manufacturer's protocols. WT or PIP5k1β −/− BMMs were seeded in 96-well plates at a density of 8×10 3 cells/well, and incubated in complete a-MEM supplemented with 20 ng/mL M-CSF for 24 h until 60% confluences, then cells were treated with 20 ng/ml M-CSF or 75 ng/ml RANKL or both for 24 h.
Then 100 ul CCK-8 buffer was added to each well, followed by incubation at 37 °C for an additional 2 h. The absorbance was then measured at a wavelength of 450 nm (650 nm reference) with an ELX800 absorbance microplate reader (Bio-Tek, USA). The migration ability was monitored with wound healing assay. In a typical procedure, a straight scratch was made gently through the monolayer cells using an Eppendorf tip in 48-well plates. Detached cells were washed away with PBS and the serum-free culture medium was added; cells were treated with 20 ng/ml M-CSF or 75 ng/ml RANKL or both. Cells migrating to the scratch were monitored and images were taken at 0, 17h after wounding. The migration rate was calculated following the equation: percentage wound healing = ((wound length at 0 h) − (wound length at 17 h))/(wound length at 0 h) × 100 (Davalos et al, 2012) .
RNA extraction and Q-PCR assay.
WT and PIP5k1β −/− BMMs were plated in six-well plates at a density of 1×10 
Western blotting
Cells were lysed on ice for 30 min with RIPA lysis buffer which contains 50 mM Tris _ HCl, pH 7.4, 150 mM NaCl, 1% Nonidet P-40, and 0.1% SDS supplemented with protease inhibitors (10 mg/ml leupeptin, 10 mg/ml pepstatin A, and 10 mg/ml aprotinin). For Western blotting, 25µg of protein sample was resolved on 12.5% SDS-PAGE and electrotransferred onto nitrocellulose membranes (Whatman, Piscataway, NJ, USA). The primary antibodies used were as follows: phospho-Akt, total Akt, phosphor -GSK3β(ser9A), PTEN, PLCγ2 and all the primary antibodies involved in the MAPK signaling pathway (phospo-p44/42 ERK, total p44/42 ERK, phospho-p38, total-p38, and phospo-JNK and total-JNK) were purchased from Cell Signaling Technology (Danvers, MA, USA) and used at a 1:1000 dilution ratio.
Anti-NFATC1 antibody was purchased from Santa Cruz and used at 1:500 dilution ratio.
Beta-actin or GAPDH was used as loading control. HRP-conjugated secondary antibodies were used at a 1:5000 dilution. The antigen-antibody complexes were visualized using the enhanced chemiluminescence detection system (Millipore, Billerica, MA, USA) following the manufacturer's instructions. Immunoreactive bands were quantitatively analyzed in triplicate by normalizing the band intensities to their respective controls on scanned films using ImageJ software.
Alkaline phosphatase staining and Alizarin red staining. The cell layer was rinsed with PBS three times, followed by fixation in 4% paraformaldehyde for 10 min at room temperature. 
